Adherence with controller medication in adults with asthma - impact of hospital admission for acute exacerbation

Autor: Charlotte Suppli Ulrik, Kjell Erik Julius Håkansson, Freja Staehr Holm

Publikováno v: The Journal of asthma : official journal of the Association for the Care of Asthma. 59(9)

OBJECTIVE Uncontrolled asthma is associated with higher risk of hospital admissions and death. Low adherence to inhaled corticosteroid (ICS), the cornerstone of asthma therapy, is well-documented. Our aim was to investigate if hospital admission with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0d1c52efde3d4d3d62ed2b1eba649c
https://pubmed.ncbi.nlm.nih.gov/34425724

Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial

Autor: Christiane Mosbech, Finn Rønholt, Charlotte Suppli Ulrik, Mia Moberg, Helle Frost Andreassen, Therese S. Lapperre, Rasmus Rude Laub, Jørgen Vestbo, Julie Janner, Aras K.M. Ali, Charlotte Sandau Bech, Pradeesh Sivapalan, Eva Brøndum, Tine Peick Sonne, Niels Seersholm, Freja Stæhr Holm, Karin Armbruster, Jon Torgny Wilcke, Praleene Sivapalan, Josefin Eklöf, Jens-Ulrik Stæhr Jensen

Publikováno v: Sivapalan, P, Lapperre, T S, Janner, J, Laub, R R, Moberg, M, Bech, C S, Eklöf, J, Holm, F S, Armbruster, K, Sivapalan, P, Mosbech, C, Ali, A K M, Seersholm, N, Wilcke, J T, Brøndum, E, Sonne, T P, Rønholt, F, Andreassen, H F, Ulrik, C S, Vestbo, J & Jensen, J S 2019, ' Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial ', The Lancet Respiratory Medicine, vol. 7, no. 8, pp. 699-709 . https://doi.org/10.1016/S2213-2600(19)30176-6
Sivapalan, P, Lapperre, T S, Janner, J, Laub, R R, Moberg, M, Bech, C S, Eklöf, J, Holm, F S, Armbruster, K, Sivapalan, P, Mosbech, C, Ali, A K M, Seersholm, N, Wilcke, J T, Brøndum, E, Sonne, T P, Rønholt, F, Andreassen, H F, Ulrik, C S, Vestbo, J & Jensen, J-U S 2019, ' Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP) : a multicentre, randomised, controlled, open-label, non-inferiority trial ', The Lancet Respiratory Medicine, vol. 7, no. 8, pp. 699-709 . https://doi.org/10.1016/S2213-2600(19)30176-6
The lancet respiratory medicine

BACKGROUND: Treatment with systemic corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) is associated with debilitating adverse effects. Therefore, strategies to reduce systemic corticosteroid exposure

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1dc768e12a9ede941c414773ff82070
https://linkinghub.elsevier.com/retrieve/pii/S2213260019301766

Risk of pneumonia or death in COPD outpatients treated with different lengths of corticosteroids

Autor: Pradeesh Sivapalan, Rikke Sørensen, Camilla B. Jensen, Kristine H. Allin, Josefin Eklöf, Daniel Bech Rasmussen, Truls Sylvan Ingebrigtsen, Freja Stæhr Holm, Karin Armbruster, Jens-Ulrik Stæhr Jensen

Publikováno v: Sivapalan, P, Rasmussen, D B, Ingebrigtsen, T S, Sorensen, R, Jensen, C B, Allin, K H, Holm, F S, Eklof, J, Armbruster, K & Jensen, J U S 2018, ' Risk of pneumonia or death in COPD outpatients treated with different lengths of corticosteroids ', European Respiratory Journal, vol. 52, no. Suppl. 62, PA785 . https://doi.org/10.1183/13993003.congress-2018.PA785

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa635e32009b491517ed1090b4bfb39b
https://doi.org/10.1183/13993003.congress-2018.pa785